bioMérieux develops and produces in vitro diagnostic solutions (systems, reagents, software and services) for private and hospital laboratories, mainly for the diagnosis of infectious diseases. The results obtained from a patient sample (blood, urine, stool, cerebrospinal fluid, saliva, etc.) provide doctors with information to support their decisions.
For 25 years, bioMérieux has also applied the expertise acquired in the clinical sector to meeting industrial microbiology needs, making it possible to manage contamination risks in agri-food, pharmaceutical and cosmetic products, at each step of the production chain.
The entrepreneurial adventure of bioMérieux is rooted in a strong family commitment to serve public health. Faithful to our pioneering spirit, our ambition is to remain a major player in infectious disease diagnostics. Thanks to our scientific approach, with no barriers between the disciplines and no geographic barriers, and bolstered by the commitment of our teams across the globe, we remain focused on this goal as part of our long-term vision.
Alexandre Mérieux, Chairman and CEO